Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Angie Goldsberry
Reata Pharmaceuticals
Dallas, TX
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
195
TOTAL CITATIONS
3
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia (MOXIe Study): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial
Number of pages: 144
Posted: 15 Jul 2020
David R. Lynch
,
Melanie P. Chin
,
Martin Delatycki
,
S.H. Subramony
,
J. Chad Hoyle
,
Sylvia Boesch
,
Wolfgang Nachbauer
,
Caterina Mariotti
,
Katherine D. Mathews
,
Paola Giunti
,
George Wilmot
,
Theresa Zesiewicz
,
Susan Perlman
, Angie Goldsberry,
Megan O’Grady
and
Colin J. Meyer
University of Pennsylvania - Division of Neurology, Reata Pharmaceuticals, University of Melbourne - Victorian Clinical Genetics Services, University of Florida - Department of Neurology, Ohio State University (OSU) - Department of Neurology, Medical University of Innsbruck - Department of Neurology, Medical University of Innsbruck - Department of Neurology, Fondazione IRCCS Istituto Neurologico ‘Carlo Besta’ - Unit of Medical Genetics and Neurogenetics, University of Iowa - Department of Neurology, Government of the United Kingdom - University College London Hospital, Emory University - Department of Neurology, University of South Florida - Ataxia Research Center, University of California, Los Angeles (UCLA) - Department of Neurology, Reata Pharmaceuticals, Reata Pharmaceuticals and Reata Pharmaceuticals
Downloads
195
(389,821)
Citation
3
View PDF
Download
Abstract:
Friedreich's ataxia; Omaveloxolone
Feedback